(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

ITEOS

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

ITEOS

ST13

US500000088914631

Class

5

Filing

88914631

Registration

7249666

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

42

Latest update

12/19/2023

Trademark type

Word

Nice classes

5

Filing date

05/13/2020

Registration date

12/19/2023

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

12/19/2023

Last transaction

12/19/2023

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

2023-06-00

First use in commerce

2023-06-00

Drawing code

4

Owner type

03

Owner location

Cambridge, MA

Examiner

LINCOSKI JR, JOHN T

Law office

O30

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

ITEOS THERAPEUTICS, INC

Representatives

Frances M Jagla CHRISTENSEN O'CONNOR JOHNSON KINDNESS

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical preparations for the treatment of oncological and autoimmune disorders

Publications

History of USPTO decisions and trademark events.

42 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

12/19/2023

R.PR

REGISTERED-PRINCIPAL REGISTER

12/19/2023

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

11/15/2023

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

11/14/2023

DOCK

ASSIGNED TO EXAMINER

11/14/2023

SUPC

STATEMENT OF USE PROCESSING COMPLETE

08/16/2023

IUAF

USE AMENDMENT FILED

08/04/2023

EISU

TEAS STATEMENT OF USE RECEIVED

08/04/2023

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

03/17/2023

NOAC

CORRECTED NOA E-MAILED

03/17/2023

EX5G

SOU EXTENSION 5 GRANTED

03/16/2023

DPCC

DIVISIONAL PROCESSING COMPLETE

03/16/2023

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

03/13/2023

EXT5

SOU EXTENSION 5 FILED

02/15/2023

DRRR

DIVISIONAL REQUEST RECEIVED

02/15/2023

ERTD

TEAS REQUEST TO DIVIDE RECEIVED

02/15/2023

EEXT

SOU TEAS EXTENSION RECEIVED

02/15/2023

EISU

TEAS STATEMENT OF USE RECEIVED

02/15/2023

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

10/22/2022

EX4G

SOU EXTENSION 4 GRANTED

10/20/2022

EXT4

SOU EXTENSION 4 FILED

10/20/2022

EEXT

SOU TEAS EXTENSION RECEIVED

10/20/2022

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

04/29/2022

EX3G

SOU EXTENSION 3 GRANTED

04/27/2022

EXT3

SOU EXTENSION 3 FILED

04/27/2022

EEXT

SOU TEAS EXTENSION RECEIVED

04/27/2022

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

11/09/2021

EX2G

SOU EXTENSION 2 GRANTED

11/05/2021

EXT2

SOU EXTENSION 2 FILED

11/05/2021

EEXT

SOU TEAS EXTENSION RECEIVED

11/05/2021

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

05/04/2021

EX1G

SOU EXTENSION 1 GRANTED

04/30/2021

EXT1

SOU EXTENSION 1 FILED

04/30/2021

EEXT

SOU TEAS EXTENSION RECEIVED

04/30/2021

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

11/10/2020

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

09/15/2020

PUBO

PUBLISHED FOR OPPOSITION

09/15/2020

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

08/26/2020

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

08/12/2020

DOCK

ASSIGNED TO EXAMINER

08/11/2020

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

05/27/2020

NWAP

NEW APPLICATION ENTERED

05/16/2020

Continuous trademark protection

Get notified about every new filing that threatens ITEOS or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.